Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies
Open Access

Impact of Matrix Metalloproteinase-8 Polymorphisms on Nasopharyngeal Carcinoma Risk

CHAO-HSUAN CHEN, YU-TING CHIN, SHIH-WEI HSU, LIANG-CHUN SHIH, HUI-CHI TIEN, CHIA-WEN TSAI, YUN-CHI WANG, YEN-FANG LIU, DA-TIAN BAU and WEN-SHIN CHANG
Anticancer Research September 2024, 44 (9) 3813-3820; DOI: https://doi.org/10.21873/anticanres.17207
CHAO-HSUAN CHEN
1Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YU-TING CHIN
2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHIH-WEI HSU
2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
4Division of Neurosurgery, Department of Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.;
5National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LIANG-CHUN SHIH
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
6Department of Otorhinolaryngology-Head and Neck Surgery, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HUI-CHI TIEN
7Department of Audiology and Speech-Language Pathology, Asia University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIA-WEN TSAI
2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUN-CHI WANG
2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YEN-FANG LIU
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DA-TIAN BAU
2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
8Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: artbau2@gmail.com
WEN-SHIN CHANG
2Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: halittlemelon@hotmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Upregulation of matrix metallo-proteinase-8 (MMP-8) serves as a protein-based indicator for predicting nasopharyngeal carcinoma (NPC) metastasis. Nevertheless, the role of MMP-8 genotypes in NPC has never been investigated. This study aimed to explore the involvement of MMP-8 genotypes in NPC development. Materials and Methods: We employed the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique to analyze MMP-8 genotypes, specifically C-799T (rs11225395), Val436Ala (rs34009635), and Lys460Thr (rs35866072), in a Taiwanese cohort comprising 208 NPC cases and 416 healthy controls. Results: Individuals with either heterozygous or homozygous variant genotypes of MMP-8 rs11225395 showed no significant change in NPC risk compared to those with the wild-type genotype [odds ratio (OR)=0.97 and 0.79, 95% confidence intervals (95%CI)=0.68-1.38 and 0.46-1.36; p=0.9304 and 0.4736, respectively]. Similarly, there was no significant association between the heterozygous genotypes of MMP-8 rs34009635 and NPC risk (OR=0.66, 95%CI=0.24-1.84; p=0.5738). For MMP-8 rs35866072, all individuals in the study were of the TT genotype. Furthermore, the presence of variant alleles at MMP-8 rs11225395 or rs34009635 did not result in altered NPC risk (OR=0.91 and 0.66, 95%CI=0.71-1.16 and 0.24-1.84, p=0.4876 and 0.5769, respectively). Additionally, no significant association was observed between MMP-8 rs11225395 variant genotypes and NPC risk among individuals regardless of smoking, alcohol consumption, or betel quid chewing habits (all p>0.05). Conclusion: There was no association between the MMP-8 genotypes rs11225395, rs34009635, or rs35866072 and NPC risk among Taiwanese individuals. Moreover, no combined effects of MMP-8 genotype with smoking, alcohol consumption, or betel quid chewing habits on NPC risk were observed.

Key Words:
  • Genotype
  • matrix metalloproteinase-8
  • nasopharyngeal carcinoma
  • polymorphism
  • Taiwan

Nasopharyngeal carcinoma (NPC) is a malignancy originating from nasopharynx epithelial cells and is associated with Epstein-Barr virus (EBV) infection, dietary practices, environmental exposures, and genetic predispositions (1-3). The molecular diagnosis of NPC is essential for early detection, choosing appropriate treatments, monitoring disease progression, and predicting outcomes. Despite the identification of several genome-wide biomarkers as potential NPC indicators (4), there is an ongoing need to uncover clinically relevant markers specifically applicable to certain populations, such as the Taiwanese (5-7).

Matrix metalloproteinase-8 (MMP-8), also referred to as neutrophil collagenase, is involved in extracellular matrix modulation through collagen degradation and is encoded by the MMP-8 gene on chromosome 11q22.3 of human genome (8, 9). This enzyme is produced not only by neutrophils, but also by various tumor cells (10, 11). Elevated levels of MMP-8 have been detected in the cyst fluids from ovarian cancer tissues compared to those of respective control tissues (12). Certain single nucleotide polymorphisms (SNPs) of MMP-8 can modify gene expression by affecting promoter activity. For instance, the MMP-8 rs11225395 T allele has been linked to increased breast cancer susceptibility and metastasis severity in both Asian and Caucasian populations (13). Over the past decades, numerous studies have explored the relationship between MMP-8 genetic variants, such as rs11225395, rs35866072, and rs1940475, and cancer risk. These investigations have spanned multiple cancer types, including bladder (14-17), skin (18), liver (19), melanoma (20), gastric (21), colorectal (22, 23), ovarian (24), oral (25), leukemia (26), lung (27), breast (28), and kidney cancer (29). However, the results regarding MMP-8 variations and cancer risk have been inconsistent across different case-control studies, and there is a notable lack of investigation on NPC.

Building on the aforementioned context, this study aims to evaluate the role of MMP-8 rs11225395, rs34009635, and rs35866072 genotypes in determining the risk of NPC in the Taiwanese population, the physical location of MMP-8 genotypes is illustrated in Figure 1. Furthermore, the investigation includes examining potential interactions between MMP-8 genotypes and lifestyle factors, such as cigarette smoking, alcohol consumption, and betel quid chewing.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Location of the MMP-8 polymorphic sites, rs11225395, rs34009635, and rs35866072, together with neighboring DNA sequences.

Materials and Methods

Recruitment of Taiwan non-cancer controls and NPC cases. A cohort of 208 NPC patients was recruited from the Department of General Surgery at China Medical University Hospital in Taichung. These participants volunteered for the study, completed a self-administered questionnaire, and provided their peripheral blood samples ranging from 3 to 5 ml. Non-cancer controls were selected in a 2:1 ratio to the cases, matched precisely by sex, age (within a 5-year range), and personal behaviors, such as cigarette smoking, alcohol consumption, and betel quid chewing. Controls were excluded if they had a history of malignancies, metastatic tumors of unknown or different origins, or any known genetic or hereditary disorders. Information on smoking, alcohol use, and betel quid chewing was gathered using the same self-reported questionnaires as those for the NPC cases. “Ever” use was defined as engaging in these behaviors more than twice a week for longer one year. These behaviors were quantified and categorized as discrete variables. The study protocols received approval and oversight from the Institutional Review Board of China Medical University Hospital (DMR101-IRB1-306). All clinical procedures and documentation strictly adhered to the principles outlined in the Declaration of Helsinki. The demographic and clinical characteristics of the NPC cases and the control group are detailed in Table I.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Demographic characteristics of the 416 control subjects and 208 NPC patients.

Genotyping methodologies for MMP-8 polymorphisms of the NPC cases and non-cancer controls. DNA was extracted from peripheral leukocytes obtained from each participant within 24 hours of collection using the QIAamp Blood Mini Kit (Qiagen, Valencia, CA, USA) (30, 31). The extracted DNA samples were stored at −80°C for long-term preservation and also diluted for use as a working stock for MMP-8 genotyping (32, 33). The genotyping of MMP-8 followed our previously published methodologies (22, 29). In brief, amplification of MMP-8 rs11225395, rs34009635, and rs35866072 was performed using a T100 Thermal Cycler 96-well system (Biorad, San Jose, CA, USA). Subsequently, restriction fragment length polymorphism analysis was conducted with the respective restriction endonucleases from New England Biolabs (Taipei, Taiwan, ROC).

Statistical analytical methodology. To ensure the control group’s representativeness within the general population, the Hardy-Weinberg equilibrium was evaluated using the goodness-of-fit test to identify any deviations in genotype frequencies. The unpaired Student’s t-test was used to compare the mean ages between NPC cases and non-cancer controls. The distribution of genotypes among different subgroups was assessed using Pearson’s Chi-square test with Yates’ correction according to our previously published papers (34, 35). A significance threshold of p less than 0.05 was applied to all statistical analyses. Logistic regression analysis was conducted to estimate the odds ratios (ORs) and 95% confidence intervals (CIs) for NPC risk associated with specific genotypes.

Results

Demographic and clinical characteristics of NPC cases and non-cancer control groups. Table I presents the frequency distributions of demographic and clinical characteristics for the 208 NPC cases and 416 non-cancer controls. Since the controls were frequency-matched to the cases by sex and age, no significant difference between the two groups was found (p=0.4639). Additionally, the histological details are shown in Table I. It is important to note that the higher proportions of smokers (38.0%), alcohol drinkers (40.4%), and betel quid chewers (37.5%) among the non-cancer controls are a result of the frequency-matching strategy and may not represent the general Taiwanese population accurately. Among the NPC cases, 3.8% were classified as keratinizing squamous cell carcinoma (WHO type I), and 96.2% as non-keratinizing carcinoma (WHO type II). The type II NPC cases were further divided into 16.0% non-keratinizing differentiated carcinoma (WHO type IIa) and 84.0% non-keratinizing undifferentiated carcinoma (WHO type IIb) (Table I).

Association of MMP-8 genotypes with NPC risk. Table II details the genotypic distributions of MMP-8 rs11225395, rs34009635, and rs35866072 among the 416 non-cancer controls and 208 NPC cases. Firstly, the genotypic frequencies of MMP-8 rs11225395 and rs34009635 in the control group adhered to the Hardy-Weinberg equilibrium (p=0.1938 and 0.7081, respectively). Secondly, there was no significant difference in the genotypic frequencies of MMP-8 rs11225395 between the NPC cases and the controls (p for trend=0.6928). Specifically, the heterozygous CT and homozygous TT genotypes of MMP-8 rs11225395 seemed to provide a protective effect against NPC risk; however, these findings were not statistically significant (OR=0.97 and 0.79, 95%CI=0.68-1.38 and 0.46-1.36, p=0.9304 and p=0.4736, respectively). This lack of significant association was further confirmed when comparing the combined CT and TT genotypes with the wild-type CC genotype (OR=0.92, 95%CI=0.66-1.29, p=0.7108). Thirdly, the heterozygous AC genotype of MMP-8 rs34009635 did not show a significant association with NPC risk (OR=0.66, 95%CI=0.24-1.84, p=0.5738). Notably, there were no individuals with the homozygous CC genotype in either the NPC or control groups. Lastly, all participants in both the NPC and control groups were found to carry the TT genotype at MMP-8 rs35866072 (Table II).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Distribution of matrix metalloproteinase-8 rs11225395, rs34009635, and rs35866072 variant genotypes among the controls and patients with NPC.

Association of MMP-8 allelic frequencies with NPC risk. To further validate the pilot findings in Table II, an allelic frequency analysis was performed to investigate the roles of MMP-8 rs11225395 and rs34009635 in NPC susceptibility. In line with the observations of Table II, the data showed no significant difference in the presence of the variant T alleles for MMP-8 rs11225395 between the NPC cases and controls (p=0.4876), with an OR of 0.91 (95%CI=0.71-1.16) for NPC risk compared to those with the wild-type C allele (Table III). Similarly, the variant C alleles for MMP-8 rs34009635 also did not show a significant difference between the two groups (p=0.5769), presenting an OR of 0.66 (95%CI=0.24-1.84) for NPC susceptibility relative to the wild-type A allele (Table III). As a result, the combined results from Table II and Table III indicate that the variant genotypes of MMP-8 rs11225395 and rs34009635 may not significantly affect the susceptibility to NPC among Taiwanese individuals.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Allelic frequencies for matrix metalloproteinase-8 rs11225395, and rs34009635 in the control and NPC patient groups.

Stratified analysis of MMP-8 rs11225395 genotypes based on personal behaviors. Our next step focused on examining the combined impact of MMP-8 rs11225395 genotype with cigarette smoking, alcohol consumption, and betel quid chewing habits on NPC risk (Table IV, Table V, and Table VI). No significant interaction was observed between MMP-8 rs11225395 genotype and cigarette smoking status, regardless of smoking status (all p>0.05) (Table IV). Similarly, there was no significant interaction between genotype and alcohol consumption status, whether individuals were non-drinkers or drinkers (Table V). Likewise, no interaction was found regarding betel quid chewing status (Table VI). We adjusted the data for age, sex, and corresponding behavioral status and re-evaluated the interactions, but still found no significance in each individual analysis (Table IV, Table V, and Table VI).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Distribution of matrix metalloproteinase-8 rs11225395 genotypes among NPC cases and controls after stratification by smoking status.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table V.

Distribution of matrix metalloproteinase-8 rs11225395 genotypes among NPC cases and controls after stratification by alcoholism status.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table VI.

Distribution of matrix metalloproteinase-8 rs11225395 genotypes among NPC cases and controls after stratification by betel quid chewing status.

Discussion

MMP-8 functions as one of the most effective collagenases, playing a pivotal role in carcinoma invasion and metastasis. Existing literature highlights MMP-8’s role in promoting the invasion of colorectal cancer cells and its potential as a prognostic marker (36, 37). However, in the context of NPC, there is a paucity of literature suggesting MMP-8 alone as a biomarker. Intriguingly, the upregulation of MMP-8, along with SLAM family member 5 (SLAMF5), endothelial cell-specific molecule-1 (ESM-1), insulin receptor (INSR), and Serpin Family A Member 5 (Serpin A5), has been associated with a protein-based signature for distant metastasis in a cohort of 226 NPC patients (38). Moreover, the mRNA expression levels of MMP-8 in peripheral blood mononuclear cells and granulocytes have been reported to function as biological markers to assess disease severity in viral lower respiratory tract infections among Netherlands children (39). MMP-8 and MMP-9 The limited research on MMP-8 in NPC may be attributed to the typically small NPC sample sizes, which are usually unsuitable for proteomic analysis. This limitation may prompt the exploration of markers from a genomic perspective rather than a protein-based approach for precise medication.

The rationale behind hypothesizing MMP-8’s potential role in NPC etiology stems from several investigations into MMP-8’s involvement in head and neck disorders. Notably, MMP-8 expression was found to be notably elevated in the serum of patients with squamous cell carcinomas of the head and neck as early as 2002 (40, 41), a finding subsequently validated in multiple studies (42-47). However, limited literature has explored the association of MMP-8 genotypes with head and neck cancer, let alone NPC. In our current study, we found that the variant genotypes of MMP-8 rs11225395 and rs34009635 are not significantly associated with altered NPC risk (Table II). At another SNP site, rs35866072, there appeared to be no polymorphism observed among Taiwanese individuals (Table II). While our pilot investigation did not unveil any clinically useful MMP-8 marker for NPC, it is noteworthy that the etiological factors contributing to NPC may vary among different populations due to differences in viral infection status, dietary habits, and genetic backgrounds, necessitating further investigations across diverse populations to validate our hypothesis. Notably, in 2019, Zhang and colleagues analyzed the association of the three MMP-8 SNPs with various malignant carcinomas, including breast, bladder, lung, and oral cancer, albeit not NPC, utilizing a database of 10,529 healthy individuals and 8,140 patients. They tentatively concluded that MMP-8 rs11225395, rs34009635, and rs35866072 variant genotypes are not associated with cancer susceptibility (48).

In addition to evaluating the impact of MMP-8 genotypes on NPC risk, our study has expanded to explore potential interactions between MMP-8 rs11225395 genotypes and behavioral factors, such as cigarette smoking, alcohol consumption, and betel quid chewing habits, related to NPC susceptibility (Table IV, Table V, and Table VI). We observed no significant association among subgroups stratified by age or sex (data not shown). Furthermore, there was no noticeable difference in susceptibility among individuals with variant MMP-8 rs11225395 genotypes, regardless of cigarette smoking, alcohol consumption, or betel quid chewing behaviors, in relation to NPC risk (Table IV, Table V, and Table VI). Previous studies have shown no combined impact of MMP-8 genotypes and cigarette smoking or alcohol consumption on renal cell carcinoma risk (29) or lung cancer risk (27). However, an interaction between cigarette smoking or alcohol consumption and the MMP-8 rs11225395 genotype has been implicated in increased colorectal cancer risk (23). The precise mechanisms by which MMP-8 genotypes influence altered NPC risk remain unclear, not to mention in combination with behavioral factors. Further investigations with larger sample sizes are urgently needed to gain deeper insight into the involvement of MMP-8 genotypes in NPC carcinogenesis.

In summary, our results indicate that variant MMP-8 genotypes may exert a modest impact on NPC susceptibility. Particularly, the MMP-8 rs11225395 genotype appears to show no significant combined effects with cigarette smoking, alcohol consumption, or betel quid chewing behaviors on individual NPC risk. Further investigation using a larger sample size and diverse population groups is essential to validate and extend our findings.

Acknowledgements

The Authors are grateful to Hou-Yu Shih for their excellent technical assistance. This study was supported by Taichung Armed Forces General Hospital (TCAFGH-D-112023), in addition to Asia and China Medical University (grand number: CMU112-ASIA-04 and ASIA-112-CMUH-17). The funders had not involved in the study design, data collection, analysis, or annotation of the manuscript.

Footnotes

  • Authors’ Contributions

    Research design: Chen CH, Hsu SW, and Chang WS; patient and questionnaire summaries: Shih LC, Tien HC, and Liu YF; experimental work: Yu-Ting Chin, Wang YC, Chang WS, and Tsai CW; data clearance and identification: Chen CH, Hsu SW, Hsu SW, and Yu-Ting Chin; statistical analysis: Yu-Ting Chin, Hsu SW, and Chang WS; literature review and manuscript writing: Chen CH, Shih LC, Yu-Ting Chin, Chang WS and Bau DT; review and revision: Hsu SW, Chang WS and Bau DT.

  • Conflicts of Interest

    The Authors declare no conflicts of interest regarding this study.

  • Received June 12, 2024.
  • Revision received July 4, 2024.
  • Accepted July 10, 2024.
  • Copyright © 2024 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

References

  1. ↵
    1. Su ZY,
    2. Siak PY,
    3. Lwin YY,
    4. Cheah S
    : Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev: 2024. DOI: 10.1007/s10555-024-10176-9
    OpenUrlCrossRef
    1. Liu H,
    2. Tang L,
    3. Li Y,
    4. Xie W,
    5. Zhang L,
    6. Tang H,
    7. Xiao T,
    8. Yang H,
    9. Gu W,
    10. Wang H,
    11. Chen P
    : Nasopharyngeal carcinoma: current views on the tumor microenvironment’s impact on drug resistance and clinical outcomes. Mol Cancer 23(1): 20, 2024. DOI: 10.1186/s12943-023-01928-2
    OpenUrlCrossRefPubMed
  2. ↵
    1. Hsu C,
    2. Chang Y,
    3. Li H
    : Molecular diagnosis of nasopharyngeal carcinoma: Past and future. Biomedical Journal: 100748, 2024. DOI: 10.1016/j.bj.2024.100748
    OpenUrlCrossRef
  3. ↵
    1. He YQ,
    2. Wang TM,
    3. Ji M,
    4. Mai ZM,
    5. Tang M,
    6. Wang R,
    7. Zhou Y,
    8. Zheng Y,
    9. Xiao R,
    10. Yang D,
    11. Wu Z,
    12. Deng C,
    13. Zhang J,
    14. Xue W,
    15. Dong S,
    16. Zhan J,
    17. Cai Y,
    18. Li F,
    19. Wu B,
    20. Liao Y,
    21. Zhou T,
    22. Zheng M,
    23. Jia Y,
    24. Li D,
    25. Cao L,
    26. Yuan L,
    27. Zhang W,
    28. Luo L,
    29. Tong X,
    30. Wu Y,
    31. Li X,
    32. Zhang P,
    33. Zheng X,
    34. Zhang S,
    35. Hu Y,
    36. Qin W,
    37. Deng B,
    38. Liang X,
    39. Fan P,
    40. Feng Y,
    41. Song J,
    42. Xie SH,
    43. Chang ET,
    44. Zhang Z,
    45. Huang G,
    46. Xu M,
    47. Feng L,
    48. Jin G,
    49. Bei J,
    50. Cao S,
    51. Liu Q,
    52. Kozlakidis Z,
    53. Mai H,
    54. Sun Y,
    55. Ma J,
    56. Hu Z,
    57. Liu J,
    58. Lung ML,
    59. Adami HO,
    60. Shen H,
    61. Ye W,
    62. Lam TH,
    63. Zeng YX,
    64. Jia WH
    : A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening. Nat Commun 13(1): 1966, 2022. DOI: 10.1038/s41467-022-29570-4
    OpenUrlCrossRef
  4. ↵
    1. Tsai CW,
    2. Shih LC,
    3. Chang WS,
    4. Hsu CL,
    5. He JL,
    6. Hsia TC,
    7. Wang YC,
    8. Gu J,
    9. Bau DT
    : Non-homologous end-joining pathway genotypes significantly associated with nasopharyngeal carcinoma susceptibility. Biomedicines 11(6): 1648, 2023. DOI: 10.3390/biomedicines11061648
    OpenUrlCrossRefPubMed
    1. Shih L,
    2. Tsai C,
    3. Chang W,
    4. Shen T,
    5. Wang Y,
    6. Yang J,
    7. Lin M,
    8. Wang Z,
    9. Bau D
    : Association of caspase-8 genotypes with the risk for nasopharyngeal carcinoma in taiwan. Anticancer Res 40(10): 5503-5508, 2020. DOI: 10.21873/anticanres.14562
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Tsai CW,
    2. Chang WS,
    3. Gong CL,
    4. Shih LC,
    5. Chen LY,
    6. Lin EY,
    7. Li HT,
    8. Yen ST,
    9. Wu CN,
    10. Bau DT
    : Contribution of matrix metallopeptidase-1 genotypes, smoking, alcohol drinking and areca chewing to nasopharyngeal carcinoma susceptibility. Anticancer Res 36(7): 3335-3340, 2016.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Fosang AJ,
    2. Last K,
    3. Neame PJ,
    4. Murphy G,
    5. Knäuper V,
    6. Tschesche H,
    7. Hughes CE,
    8. Caterson B,
    9. Hardingham TE
    : Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem J 304 (Pt 2)(Pt 2): 347-351, 1994. DOI: 10.1042/bj3040347
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Gutierrez-Fernandez A,
    2. Fueyo A,
    3. Folgueras AR,
    4. Garabaya C,
    5. Pennington CJ,
    6. Pilgrim S,
    7. Edwards DR,
    8. Holliday DL,
    9. Jones JL,
    10. Span PN,
    11. Sweep FC,
    12. Puente XS,
    13. Lopez-Otin C
    : Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res 68(8): 2755-2763, 2008. DOI: 10.1158/0008-5472.CAN-07-5154
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Stadlmann S,
    2. Pollheimer J,
    3. Moser P,
    4. Raggi A,
    5. Amberger A,
    6. Margreiter R,
    7. Offner F,
    8. Mikuz G,
    9. Dirnhofer S,
    10. Moch H
    : Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer. Eur J Cancer 39(17): 2499-2505, 2003. DOI: 10.1016/j.ejca.2003.08.011
    OpenUrlCrossRefPubMed
  9. ↵
    1. Sirnio P,
    2. Tuomisto A,
    3. Tervahartiala T,
    4. Sorsa T,
    5. Klintrup K,
    6. Karhu T,
    7. Herzig KH,
    8. Makela J,
    9. Karttunen TJ,
    10. Salo T,
    11. Makinen MJ,
    12. Vayrynen JP
    : High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer. Br J Cancer 119(2): 213-219, 2018. DOI: 10.1038/s41416-018-0136-4
    OpenUrlCrossRefPubMed
  10. ↵
    1. Stenman M,
    2. Paju A,
    3. Hanemaaijer R,
    4. Tervahartiala T,
    5. Leminen A,
    6. Stenman U,
    7. Konttinen Y,
    8. Sorsa T
    : Collagenases (MMP-1, -8 and -13) and trypsinogen-2 in fluid from benign and malignant ovarian cysts. Tumour Biol 24(1): 9-12, 2003. DOI: 10.1159/000070655
    OpenUrlCrossRefPubMed
  11. ↵
    1. Decock J,
    2. Long J,
    3. Laxton RC,
    4. Shu X,
    5. Hodgkinson C,
    6. Hendrickx W,
    7. Pearce EG,
    8. Gao Y,
    9. Pereira AC,
    10. Paridaens R,
    11. Zheng W,
    12. Ye S
    : Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis. Cancer Res 67(21): 10214-10221, 2007. DOI: 10.1158/0008-5472.CAN-07-1683
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Wieczorek E,
    2. Reszka E,
    3. Wasowicz W,
    4. Grzegorczyk A,
    5. Konecki T,
    6. Sosnowski M,
    7. Jablonowski Z
    : MMP7 and MMP8 genetic polymorphisms in bladder cancer patients. Cent European J Urol 66(4): 405-410, 2014. DOI: 10.5173/ceju.2013.04.art3
    OpenUrlCrossRefPubMed
    1. Kader AK,
    2. Shao L,
    3. Dinney CP,
    4. Schabath MB,
    5. Wang Y,
    6. Liu J,
    7. Gu J,
    8. Grossman HB,
    9. Wu X
    : Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res 66(24): 11644-11648, 2006. DOI: 10.1158/0008-5472.CAN-06-1212
    OpenUrlAbstract/FREE Full Text
    1. Srivastava P,
    2. Kapoor R,
    3. Mittal RD
    : Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India. Urol Oncol 31(2): 247-254, 2013. DOI: 10.1016/j.urolonc.2011.01.001
    OpenUrlCrossRefPubMed
  13. ↵
    1. Tsai T,
    2. Wang Y,
    3. Chang W,
    4. Tsai C,
    5. Wu H,
    6. Hsu H,
    7. Wang Y,
    8. Li H,
    9. Gong C,
    10. Bau D,
    11. Li C
    : Association of matrix metalloproteinase-8 genotypes with the risk of bladder cancer. Anticancer Res 38(9): 5159-5164, 2018. DOI: 10.21873/anticanres.12838
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Nan H,
    2. Niu T,
    3. Hunter DJ,
    4. Han J
    : Missense polymorphisms in matrix metalloproteinase genes and skin cancer risk. Cancer Epidemiol Biomarkers Prev 17(12): 3551-3557, 2008. DOI: 10.1158/1055-9965.EPI-08-0606
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Qiu W,
    2. Zhou G,
    3. Zhai Y,
    4. Zhang X,
    5. Xie W,
    6. Zhang H,
    7. Yang H,
    8. Zhi L,
    9. Yuan X,
    10. Zhang X,
    11. He F
    : No Association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a chinese population. Cancer Epidemiol Biomarkers Prev 17(9): 2514-2518, 2008. DOI: 10.1158/1055-9965.EPI-08-0557
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Debniak T,
    2. Jakubowska A,
    3. Serrano-Fernandez P,
    4. Kurzawski G,
    5. Cybulski C,
    6. Chauhan SR,
    7. Laxton RC,
    8. Maleszka R,
    9. Lubinski J,
    10. Ye S
    : Association of MMP8 gene variation with an increased risk of malignant melanoma. Melanoma Res 21(5): 464-468, 2011. DOI: 10.1097/CMR.0b013e3283485fdd
    OpenUrlCrossRefPubMed
  17. ↵
    1. Kim JH,
    2. Pyun J,
    3. Lee KJ,
    4. Cho SW,
    5. Kwack KB
    : Study on association between single nucleotide polymorphisms ofMMP7, MMP8, MMP9 genes and development of gastric cancer and lymph node metastasis. Korean J Gastroenterol 58(5): 245, 2011. DOI: 10.4166/kjg.2011.58.5.245
    OpenUrlCrossRefPubMed
  18. ↵
    1. Deng Y,
    2. Ke T,
    3. Wang Y,
    4. Chin Y,
    5. Yueh T,
    6. Hung Y,
    7. Mong M,
    8. Yang Y,
    9. Chang W,
    10. Shen T,
    11. Bau D,
    12. Tsai C
    : Impact of matrix metalloproteinase-8 genotypes on colorectal cancer risk in Taiwan. Anticancer Res 43(9): 3979-3985, 2023. DOI: 10.21873/anticanres.16585
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Tai J,
    2. Sun D,
    3. Wang X,
    4. Kang Z
    : Matrix metalloproteinase-8 rs11225395 polymorphism correlates with colorectal cancer risk and survival in a Chinese Han population: a case-control study. Aging (Albany NY) 12(19): 19618-19627, 2020. DOI: 10.18632/aging.103930
    OpenUrlCrossRef
  20. ↵
    1. Arechavaleta-Velasco F,
    2. Cuevas-Antonio R,
    3. Dominguez-Lopez P,
    4. Estrada-Moscoso I,
    5. Imani-Razavi FS,
    6. Zeferino-Toquero M,
    7. Diaz-Cueto L
    : Matrix metalloproteinase-8 promoter gene polymorphisms in Mexican women with ovarian cancer. Med Oncol 31(8): 132, 2014. DOI: 10.1007/s12032-014-0132-3
    OpenUrlCrossRefPubMed
  21. ↵
    1. Hung YW,
    2. Tsai CW,
    3. Wu CN,
    4. Shih LC,
    5. Chen YY,
    6. Liu YF,
    7. Hung HS,
    8. Shen MY,
    9. Chang WS,
    10. Bau DT
    : The contribution of matrix metalloproteinase-8 promoter polymorphism to oral cancer susceptibility. In Vivo 31(4): 585-590, 2017. DOI: 10.21873/invivo.11098
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Pei JS,
    2. Chang WS,
    3. Hsu PC,
    4. Hung YW,
    5. Cheng SP,
    6. Tsai CW,
    7. Bau DT,
    8. Gong CL
    : The contribution of MMP-8 promoter genotypes to childhood leukemia. In Vivo 31(6): 1059-1064, 2017. DOI: 10.21873/invivo.11170
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Shen TC,
    2. Hsia TC,
    3. Chao CY,
    4. Chen WC,
    5. Chen CY,
    6. Chen WC,
    7. Lin YT,
    8. Hsiao CL,
    9. Chang WS,
    10. Tsai CW,
    11. Bau DT
    : The contribution of MMP-8 promoter polymorphisms in lung cancer. Anticancer Res 37(7): 3563-3567, 2017. DOI: 10.21873/anticanres.11726
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Hsiao CL,
    2. Liu LC,
    3. Shih TC,
    4. Chuang CL,
    5. Chen GL,
    6. Wang HC,
    7. Pan SY,
    8. Shen TC,
    9. Tsai CW,
    10. Chang WS,
    11. Way TD,
    12. Chung JG,
    13. Bau DT
    : The association of matrix metalloproteinase-8 promoter genotypes in breast cancer. Anticancer Res 38(4): 2181-2185, 2018. DOI: 10.21873/anticanres.12459
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Liao C,
    2. Chien W,
    3. Chang S,
    4. Lin Y,
    5. Wang Y,
    6. Huang W,
    7. Mong M,
    8. Yang Y,
    9. Wu W,
    10. Chen J,
    11. Chang C,
    12. Tsai C,
    13. Bau D,
    14. Chang W
    : Associations of matrix metalloproteinase-8 genotypes to renal cell carcinoma in Taiwan. Anticancer Res 44(5): 1931-1938, 2024. DOI: 10.21873/anticanres.16995
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Chen L,
    2. Tsai Y,
    3. Wu W,
    4. Chiu K,
    5. Tsai C,
    6. Chang W,
    7. Li C,
    8. Yang J,
    9. Mong M,
    10. Hsia T,
    11. Bau D
    : Association of matrix metalloproteinase-9 genotypes with lung cancer risk in Taiwan. Anticancer Res 44(5): 1845-1852, 2024. DOI: 10.21873/anticanres.16986
    OpenUrlAbstract/FREE Full Text
  27. ↵
    1. Yang MD,
    2. Lin KC,
    3. Lu MC,
    4. Jeng LB,
    5. Hsiao CL,
    6. Yueh TC,
    7. Fu CK,
    8. Li HT,
    9. Yen ST,
    10. Lin CW,
    11. Wu CW,
    12. Pang SY,
    13. Bau DT,
    14. Tsai FJ
    : Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan. Biomedicine (Taipei) 7(2): 10, 2017. DOI: 10.1051/bmdcn/2017070203
    OpenUrlCrossRefPubMed
  28. ↵
    1. Chiu K,
    2. Wang S,
    3. Li C,
    4. Shen T,
    5. Chen L,
    6. Shen Y,
    7. Chang W,
    8. Tsai C,
    9. Hsia T,
    10. Bau D
    : The contribution of double-strand break repair radiation sensitive protein 51 genotypes to lung cancer in taiwan. Anticancer Res 44(4): 1409-1416, 2024. DOI: 10.21873/anticanres.16937
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Chen CC,
    2. Chang WS,
    3. Pei JS,
    4. Kuo CC,
    5. Wang CH,
    6. Wang YC,
    7. Hsu PC,
    8. He JL,
    9. Gu J,
    10. Bau DT,
    11. Tsai CW
    : Non-homologous end-joining genotype, mRNA expression, and DNA repair capacity in childhood acute lymphocytic leukemia. Cancer Genomics Proteomics 21(2): 144-157, 2024. DOI: 10.21873/cgp.20436
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Yueh TC,
    2. Wu CN,
    3. Hung YW,
    4. Chang WS,
    5. Fu CK,
    6. Pei JS,
    7. Wu MH,
    8. Lai YL,
    9. Lee YM,
    10. Yen ST,
    11. Li HT,
    12. Tsai CW,
    13. Bau DT
    : The contribution of MMP-7 genotypes to colorectal cancer susceptibility in Taiwan. Cancer Genomics Proteomics 15(3): 207-212, 2018. DOI: 10.21873/cgp.20079
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Wu MH,
    2. Yueh TC,
    3. Chang WS,
    4. Tsai CW,
    5. Fu CK,
    6. Yang MD,
    7. Yu CC,
    8. Bau DT
    : Contribution of matrix metalloproteinase-1 genotypes to colorectal cancer in Taiwan. Cancer Genomics Proteomics 18(3): 245-251, 2021. DOI: 10.21873/cgp.20255
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Bockelman C,
    2. Beilmann-Lehtonen I,
    3. Kaprio T,
    4. Koskensalo S,
    5. Tervahartiala T,
    6. Mustonen H,
    7. Stenman UH,
    8. Sorsa T,
    9. Haglund C
    : Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer. BMC Cancer 18(1): 679, 2018. DOI: 10.1186/s12885-018-4589-x
    OpenUrlCrossRefPubMed
  33. ↵
    1. Juurikka K,
    2. Butler GS,
    3. Salo T,
    4. Nyberg P,
    5. Astrom P
    : The role of MMP8 in cancer: A systematic review. Int J Mol Sci 20(18): 4506, 2019. DOI: 10.3390/ijms20184506
    OpenUrlCrossRefPubMed
  34. ↵
    1. Liang Y,
    2. Li J,
    3. Li Q,
    4. Tang L,
    5. Chen L,
    6. Mao Y,
    7. He Q,
    8. Yang X,
    9. Lei Y,
    10. Hong X,
    11. Zhao Y,
    12. He S,
    13. Guo Y,
    14. Wang Y,
    15. Zhang P,
    16. Liu N,
    17. Li Y,
    18. Ma J
    : Plasma protein-based signature predicts distant metastasis and induction chemotherapy benefit in Nasopharyngeal Carcinoma. Theranostics 10(21): 9767-9778, 2020. DOI: 10.7150/thno.47882
    OpenUrlCrossRefPubMed
  35. ↵
    1. Brand KH,
    2. Ahout IM,
    3. de Groot R,
    4. Warris A,
    5. Ferwerda G,
    6. Hermans PW
    : Use of MMP-8 and MMP-9 to assess disease severity in children with viral lower respiratory tract infections. J Med Virol 84(9): 1471-1480, 2012. DOI: 10.1002/jmv.23301
    OpenUrlCrossRefPubMed
  36. ↵
    1. Kuropkat C,
    2. Plehn S,
    3. Herz U,
    4. Dunne AA,
    5. Renz H,
    6. Werner JA
    : Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer. Anticancer Res 22(4): 2221-2227, 2002.
    OpenUrlPubMed
  37. ↵
    1. Moilanen M,
    2. Pirilä E,
    3. Grénman R,
    4. Sorsa T,
    5. Salo T
    : Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas. J Pathol 197(1): 72-81, 2002. DOI: 10.1002/path.1078
    OpenUrlCrossRefPubMed
  38. ↵
    1. Kuropkat C,
    2. Duenne AA,
    3. Herz U,
    4. Renz H,
    5. Werner JA
    : Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer. Neoplasma 51(5): 375-378, 2004.
    OpenUrlPubMed
    1. Nurmenniemi S,
    2. Koivula M,
    3. Nyberg P,
    4. Tervahartiala T,
    5. Sorsa T,
    6. Mattila PS,
    7. Salo T,
    8. Risteli J
    : Type I and III collagen degradation products in serum predict patient survival in head and neck squamous cell carcinoma. Oral Oncol 48(2): 136-140, 2012. DOI: 10.1016/j.oraloncology.2011.09.002
    OpenUrlCrossRefPubMed
    1. Musrati AA,
    2. Tervahartiala T,
    3. Gursoy M,
    4. Kononen E,
    5. Fteita D,
    6. Sorsa T,
    7. Uitto VJ,
    8. Gursoy UK
    : Human neutrophil peptide-1 affects matrix metalloproteinase-2, -8 and -9 secretions of oral squamous cell carcinoma cell lines in vitro. Arch Oral Biol 66: 1-7, 2016. DOI: 10.1016/j.archoralbio.2016.02.003
    OpenUrlCrossRefPubMed
    1. Cai M,
    2. Zheng Z,
    3. Bai Z,
    4. Ouyang K,
    5. Wu Q,
    6. Xu S,
    7. Huang L,
    8. Jiang Y,
    9. Wang L,
    10. Gao J,
    11. Pathak JL,
    12. Wu L
    : Overexpression of angiogenic factors and matrix metalloproteinases in the saliva of oral squamous cell carcinoma patients: potential non-invasive diagnostic and therapeutic biomarkers. BMC Cancer 22(1): 530, 2022. DOI: 10.1186/s12885-022-09630-0
    OpenUrlCrossRef
    1. Kazmi A,
    2. Abbas Z,
    3. Saleem Z,
    4. Haider S,
    5. Farooqui WA,
    6. Ahmed S
    : Relation of salivary MMP-8 with oral submucous fibrosis and oral squamous cell carcinoma: A cross sectional analytical study. BMJ Open 12(12): e060738, 2022. DOI: 10.1136/bmjopen-2021-060738
    OpenUrlCrossRef
  39. ↵
    1. Brandt E,
    2. Keskin M,
    3. Tervahartiala T,
    4. Yılmaz M,
    5. Harmankaya İ,
    6. Karaçetin D,
    7. İpek T,
    8. Gürsoy UK,
    9. Rautava J,
    10. Gupta S,
    11. Hagström J,
    12. Räisänen IT,
    13. Sorsa T
    : Radiotherapy increases aMMP-8-levels and neutrophil/lymphocyte ratio rapidly in head and neck cancer patients: A Pilot Study. Cancer Control 30: 10732748231163653, 2023. DOI: 10.1177/10732748231163653
    OpenUrlCrossRef
  40. ↵
    1. Zhang LF,
    2. Zhu LJ,
    3. Zhang W,
    4. Yuan W,
    5. Song NH,
    6. Zuo L,
    7. Mi YY,
    8. Wang ZJ,
    9. Zhang W
    : MMP-8 C-799 T, Lys460Thr, and Lys87Glu variants are not related to risk of cancer. BMC Med Genet 20(1): 162, 2019. DOI: 10.1186/s12881-019-0890-z
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

Anticancer Research: 44 (9)
Anticancer Research
Vol. 44, Issue 9
September 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Matrix Metalloproteinase-8 Polymorphisms on Nasopharyngeal Carcinoma Risk
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Impact of Matrix Metalloproteinase-8 Polymorphisms on Nasopharyngeal Carcinoma Risk
CHAO-HSUAN CHEN, YU-TING CHIN, SHIH-WEI HSU, LIANG-CHUN SHIH, HUI-CHI TIEN, CHIA-WEN TSAI, YUN-CHI WANG, YEN-FANG LIU, DA-TIAN BAU, WEN-SHIN CHANG
Anticancer Research Sep 2024, 44 (9) 3813-3820; DOI: 10.21873/anticanres.17207

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Impact of Matrix Metalloproteinase-8 Polymorphisms on Nasopharyngeal Carcinoma Risk
CHAO-HSUAN CHEN, YU-TING CHIN, SHIH-WEI HSU, LIANG-CHUN SHIH, HUI-CHI TIEN, CHIA-WEN TSAI, YUN-CHI WANG, YEN-FANG LIU, DA-TIAN BAU, WEN-SHIN CHANG
Anticancer Research Sep 2024, 44 (9) 3813-3820; DOI: 10.21873/anticanres.17207
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Association of Matrix Metalloproteinase-7 Genotypes With Nasopharyngeal Carcinoma Risk
  • Impact of DNA Ligase 1 Genotypes on Childhood Acute Lymphocytic Leukemia
  • Google Scholar

More in this TOC Section

  • Role of Platelet Interactions in Promoting Melanoma Malignancy With Insights into Proliferation, Cyclin D1 Expression, and Migration
  • Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis Lung Carcinoma Cells But Not Normal Fibroblasts
  • Light Bladder Net: Non-invasive Bladder Cancer Prediction by Weighted Deep Learning Approaches and Graphical Data Transformation
Show more Experimental Studies

Similar Articles

Keywords

  • genotype
  • matrix metalloproteinase-8
  • nasopharyngeal carcinoma
  • polymorphism
  • Taiwan
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire